Personalized medicine using DNA biomarkers: A review

Andreas Ziegler*, Armin Koch, Katja Krockenberger, Anika Großhennig

*Corresponding author for this work
115 Citations (Scopus)


Biomarkers are of increasing importance for personalized medicine, with applications including diagnosis, prognosis, and selection of targeted therapies. Their use is extremely diverse, ranging from pharmacodynamics to treatment monitoring. Following a concise review of terminology, we provide examples and current applications of three broad categories of biomarkers-DNA biomarkers, DNA tumor biomarkers, and other general biomarkers. We outline clinical trial phases for identifying and validating diagnostic and prognostic biomarkers. Predictive biomarkers, more generally termed companion diagnostic tests predict treatment response in terms of efficacy and/or safety. We consider suitability of clinical trial designs for predictive biomarkers, including a detailed discussion of validation study designs, with emphasis on interpretation of study results. We specifically discuss the interpretability of treatment effects if a large set of DNA biomarker profiles is available and the number of therapies is identical to the number of different profiles.

Original languageEnglish
JournalHuman Genetics
Issue number10
Pages (from-to)1627-1638
Number of pages12
Publication statusPublished - 10.2012


Dive into the research topics of 'Personalized medicine using DNA biomarkers: A review'. Together they form a unique fingerprint.

Cite this